Systemic amiloride inhibits induced neovascularization Amiloride inhibitor urokinase-type plasminogen activator inhibitory effect neovascularization Neovascularization rabbit corneas local implantation prostaglandin pellets slow-release polymer Animals daily intraperitoneal injections mg amiloride equivalent volume saline solution days severe untoward effect Neovascular response corneal photographs days injections area induced corneal neovascularization animals controls similar compounds useful study management neovascularization 